Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Surveying and Optimizing the Predictors for Ependymoma Specific Survival using SEER Data

  • Published : 2014.01.30
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: This study used receiver operating characteristic curve to analyze Surveillance, Epidemiology and End Results (SEER) ependymoma data to identify predictive models and potential disparity in outcome. Materials and Methods: This study analyzed socio-economic, staging and treatment factors available in the SEER database for ependymoma. For the risk modeling, each factor was fitted by a Generalized Linear Model to predict the outcome ('brain and other nervous systems' specific death in yes/no). The area under the receiver operating characteristic curve (ROC) was computed. Similar strata were combined to construct the most parsimonious models. A random sampling algorithm was used to estimate the modeling errors. Risk of ependymoma death was computed for the predictors for comparison. Results: A total of 3,500 patients diagnosed from 1973 to 2009 were included in this study. The mean follow up time (S.D.) was 79.8 (82.3) months. Some 46% of the patients were female. The mean (S.D.) age was 34.4 (22.8) years. Age was the most predictive factor of outcome. Unknown grade demonstrated a 15% risk of cause specific death compared to 9% for grades I and II, and 36% for grades III and IV. A 5-tiered grade model (with a ROC area 0.48) was optimized to a 3-tiered model (with ROC area of 0.53). This ROC area tied for the second with that for surgery. African-American patients had 21.5% risk of death compared with 16.6% for the others. Some 72.7% of patient who did not get RT had cerebellar or spinal ependymoma. Patients undergoing surgery had 16.3% risk of death, as compared to 23.7% among those who did not have surgery. Conclusion: Grading ependymoma may dramatically improve modeling of data. RT is under used for cerebellum and spinal cord ependymoma and it may be a potential way to improve outcome.

Keywords

References

  1. Amirian ES, Armstrong TS, Gilbert MR, Scheurer ME (2012). Predictors of survival among older adults with ependymoma. J Neurooncol, 107, 183-9. https://doi.org/10.1007/s11060-011-0730-2
  2. Bishop AJ, McDonald MW, Chang AL, Esiashvili N (2012). Infant brain tumors: incidence, survival, and the role of radiation based on Surveillance, Epidemiology, and End Results (SEER) Data. Int J Radiat Oncol Biol Phys, 82, 341-7. https://doi.org/10.1016/j.ijrobp.2010.08.020
  3. Cheung R (2012). Poor treatment outcome of neuroblastoma and other peripheral nerve cell tumors may be related to under usage of radiotherapy and socio-economic disparity: a US SEER data analysis. Asian Pac J Cancer Prev, 13, 4587-91. https://doi.org/10.7314/APJCP.2012.13.9.4587
  4. Cheung R, Altschuler MD, D'Amico AV, et al (2001a). ROCoptimization may improve risk stratification of prostate cancer patients. Urology, 57, 286-90. https://doi.org/10.1016/S0090-4295(00)00911-0
  5. Cheung R, Altschuler MD, D'Amico AV, et al (2001b). Using the receiver operator characteristic curve to select pretreatment and pathologic predictors for early and late post-prostatectomy PSA failure. Urology, 58, 400-5. https://doi.org/10.1016/S0090-4295(01)01209-2
  6. Cohen RJ, Curtis RE, Inskip PD, Fraumeni JF Jr (2005). The risk of developing second cancers among survivors of childhood soft tissue sarcoma. Cancer, 103, 2391-6. https://doi.org/10.1002/cncr.21040
  7. D'Amico AV, Desjardin A, Chung A, et al. (1998). Assessment of outcome prediction models for patients with localized prostate carcinoma managed with radical prostatectomy or external beam radiation therapy. Cancer, 82, 1887-96. https://doi.org/10.1002/(SICI)1097-0142(19980515)82:10<1887::AID-CNCR11>3.0.CO;2-P
  8. DeLaney TF. (2007). Clinical proton radiation therapy research at the Francis H. Burr Proton Therapy Center. Technol Cancer Res Treat, 6, 61-6. https://doi.org/10.1177/15330346070060S410
  9. Hanley JA, McNeil BJ (1982). The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology, 143, 29-36. https://doi.org/10.1148/radiology.143.1.7063747
  10. Koshy M, Rich S, Merchant TE, et al (2011). Post-operative radiation improves survival in children younger than 3 years with intracranial ependymoma. J Neurooncol, 105, 583-90. https://doi.org/10.1007/s11060-011-0624-3
  11. Kuhlthau KA, Pulsifer MB, Yeap BY, et al (2012). Prospective study of health-related quality of life for children with brain tumors treated with proton radiotherapy. J Clin Oncol, 30, 2079-86. https://doi.org/10.1200/JCO.2011.37.0577
  12. McGuire CS, Sainani KL, Fisher PG (2009). Incidence patterns for ependymoma: a surveillance, epidemiology, and end results study. J Neurosurg, 110, 725-9. https://doi.org/10.3171/2008.9.JNS08117
  13. Miralbell R, Lomax A, Cella L, Schneider U (2002). Potential reduction of the incidence of radiation-induced second cancers by using proton beams in the treatment of pediatric tumors. Int J Radiat Oncol Biol Phys, 54, 824-9. https://doi.org/10.1016/S0360-3016(02)02982-6
  14. Rodriguez D, Cheung MC, Housri N, et al (2009). Outcomes of malignant CNS ependymomas: an examination of 2408 cases through the Surveillance, Epidemiology, and End Results (SEER) database (1973-2005). J Surg Res, 156, 340-51. https://doi.org/10.1016/j.jss.2009.04.024

Cited by

  1. Probability Sampling Method for a Hidden Population Using Respondent-Driven Sampling: Simulation for Cancer Survivors vol.16, pp.11, 2015, https://doi.org/10.7314/APJCP.2015.16.11.4677
  2. Analysis of SEER Adenosquamous Carcinoma Data to Identify Cause Specific Survival Predictors and Socioeconomic Disparities vol.17, pp.1, 2016, https://doi.org/10.7314/APJCP.2016.17.1.347
  3. Analysis of SEER Glassy Cell Carcinoma Data: Underuse of Radiotherapy and Predicators of Cause Specific Survival vol.17, pp.1, 2016, https://doi.org/10.7314/APJCP.2016.17.1.353